SSII
NASDAQ · Health Care
Ss Innovations International
$1.90
-0.37 (-16.30%)
Financial Highlights (FY 2026)
Revenue
51.90M
Net Income
-14,810,079
Gross Margin
46.0%
Profit Margin
-28.6%
Rev Growth
—
D/E Ratio
0.30
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 46.0% | 50.7% | 50.7% | 50.7% |
| Operating Margin | -19.3% | 15.8% | 14.1% | 14.1% |
| Profit Margin | -28.6% | 14.0% | 15.1% | 11.5% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 51.90M | 294.54M | 262.27M | 240.92M |
| Gross Profit | 23.88M | 149.45M | 133.07M | 122.24M |
| Operating Income | -10,012,458 | 46.64M | 37.10M | 34.03M |
| Net Income | -14,810,079 | 41.36M | 39.46M | 27.71M |
| Gross Margin | 46.0% | 50.7% | 50.7% | 50.7% |
| Operating Margin | -19.3% | 15.8% | 14.1% | 14.1% |
| Profit Margin | -28.6% | 14.0% | 15.1% | 11.5% |
| Rev Growth | — | +7.6% | +2.3% | +6.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 50.81M | 118.45M | 152.33M | 135.17M |
| Total Equity | 169.71M | 508.27M | 516.61M | 488.41M |
| D/E Ratio | 0.30 | 0.23 | 0.29 | 0.28 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -8,704,983 | 48.96M | 47.08M | 43.40M |
| Free Cash Flow | — | 24.60M | 19.43M | 18.07M |